Notify me when 7. Cooperative UA LSP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | Common Stock, $0.0001 par value per share | 15% | $114,491,976 | +$7,765,422 | 5,288,313 | +7.3% | LSP 7 Cooperatieve U.A. | 12 Feb 2026 |
| OCS | Oculis Holding AG | Ordinary Shares, par value CHF 0.10 per share | 14% | $101,078,348 | 5,752,894 | LSP 7 Cooperatieve U.A. | 31 Dec 2024 | ||
| AgomAb Therapeutics NV | Common Shares, no nominal value per share ("Common Shares") | 11% | 5,141,992 | LSP 7 Cooperatieve U.A. | 09 Feb 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|